NEW YORK - Bankrupt pharmaceutical maker Quigley Co. Inc., a subsidiary of Pfizer Inc., on Nov. 5 moved in the U.S. Bankruptcy Court for the Southern District of New York for an extension of the voting deadline to approve its reorganization plan until the end of the month (In Re: Quigley Company Inc., No. 04-15739, Chapter 11, S.D. N.Y. Bkcy.). Subscribers may view the motion available within the full article.